Giammarco Mocci Selected Research

Giammarco Mocci Research Topics

17	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2024 - 06/2009
15	Ulcerative Colitis 01/2024 - 06/2009
10	Crohn Disease (Crohn's Disease) 01/2023 - 10/2008
5	Necrosis 01/2022 - 11/2013
2	Inflammation (Inflammations) 11/2014 - 01/2008
2	Hepatitis B 03/2013 - 06/2009
2	Infections 03/2013 - 06/2009
1	Pouchitis 03/2024
1	Diverticular Diseases 03/2023
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 03/2023
1	Colorectal Neoplasms (Colorectal Cancer) 03/2023
1	Collagenous Sprue 11/2021
1	Sclerosing Cholangitis 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019
1	Psoriatic Arthritis 01/2019
1	Liver Diseases (Liver Disease) 07/2018
1	Fistula 02/2015
1	Latent Infection 03/2013
1	Latent Tuberculosis 06/2009
1	Neoplasms (Cancer) 06/2009
1	Thrombosis (Thrombus) 01/2008

7	Ustekinumab (CNTO 1275)FDA Link 03/2024 - 01/2019
6	Biosimilar PharmaceuticalsIBA 01/2023 - 12/2017
6	Adalimumab (Humira)FDA Link 01/2023 - 08/2018
6	Infliximab (Remicade)FDA Link 02/2022 - 06/2009
5	vedolizumabIBA 01/2023 - 08/2019
4	SteroidsIBA 01/2021 - 01/2008
3	CT-P13IBA 02/2022 - 12/2017
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 06/2009
3	golimumab FDA Link 12/2021 - 09/2017
2	tofacitinibIBA 09/2023 - 01/2021
2	GP2017IBA 01/2023 - 07/2022
2	Therapeutic UsesIBA 07/2018 - 11/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2024
1	Interleukin-23 (Interleukin 23)IBA 01/2024
1	Interleukin-12 (IL 12)IBA 01/2024
1	Mesalamine (Mesalazine)FDA LinkGeneric 03/2023
1	olmesartanIBA 11/2021
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 11/2014
1	Tumor Necrosis Factor InhibitorsIBA 11/2013
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 10/2008
1	Phenobarbital (Luminal)FDA Link 10/2008